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Although both fluorescein isothiocyanate (FITC) and 
t rinitrophenyl (TNP) covalently couple primarily to the 
t-amino group of lysine residues of surface glycoprotein , 
F I TC is structurally different from TNP. In this paper, 
we investigated the immune regulatory mechanisms in 
contact sensitivity (CS) to FITC by the a dministration 
of FITC and FITC-conjugated epidermal cells (FITC-
EC) via various routes. Mice injected with FITC via i.p. 
or i. v. route did not induce CS but induced hyporespon-
siveness to the following sensitization with FITC paint-
ing. Mice injected with FITC via s.c. route induced nei-
ther CS nor hyporesponsiveness to the following FITC 
painting. Administration of FITC via i.v. route was 
demonstrated to induce hapten-specific suppressor T 
cells. Inoculation of FITC-EC via s.c. or i.p. route in-
duced CS, whereas injection of FITC-EC via i.v. route 
did not induce CS but induced hyporesponsiveness to the 
f ollowing FITC painting. 
The results are compared with the previous data ob-
t ained by trinitrobenze ne sulfonate and trinitrophenyl-
conjugated epidermal cells. 
It has been well established t hat epicu taneous application of 
h a p te ns can induce contact se nsit ivity (CS). Furt he rmore, it 
was demonstrated that int racuta neous administration of hap-
ten s could induce CS, whereas when t hese hap tens were given 
by any other route t hey could not induce CS [1- 3]. It has a lso 
been suggested that differen t water solubility of ha pte ns m ay 
e lici t different types of immunologic respon ses [ 4]. 
Trinit robe nzene sulfonic acid (TNBS ) cova len t ly couples t he 
t rinit ropheny l (TNP) hap ten a lmost exclus ive ly to t he f-a mino 
groups of cell lysine residues [5], a nd has been used fo r in vivo 
studies [6,7] . Haptens othe r t han TNP ha ve a lso been conju -
g a ted to cell surface proteins, a nd have been used for in vivo 
d e layed type hypersens it ivi t y (DTH) a nd CS reactions [8,9] . 
Fluorescein isot hiocyanate (FITC ) conjugat es to availa ble 
am ino groups on t he cell surface, m an y of which must be t he 
sam e as those t hat react wit h TNP. 
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S ince FITC is structura lly diffe ren t from TNP, t his h apte n 
has been in vestigated exten sively f or in vitro studies of a n ti-
body specificit y [10,11], a nd of T ce ll-m ediated cytotoxicity 
[5,12]. There a re, however , only a few rep orts of t his h apten 
fo r in vivo studies [4,1 3]. 
In t his paper , we investigated t he immune regulatory mech -
a nis ms in CS to FITC by administration of free FITC a n d 
FITC-conjugated epide rma l cells (FITC-EC) via various rou tes. 
The results a re discussed with t he previous results ob tained by 
TNBS a nd t rinit rophenyl-co njuga ted epiderm a l cells (TNP-
E C ). 
MATERIALS AN D METHODS 
Mice 
BALB/c AnNCrj and BALB/ c crSlc fe male and male mice were 
obta ined from eit her Charles River, J apan, or Shizuoka Breeding 
Laboratories, Japan. All mice were 8- 12 weeks of age when used in 
t hese experiments. Four or five mice were used in each group. 
Antigens 
Fluorescein isothiocyanate isomer I (FITC, S igma Chemical Co., St. 
Louis Missouri ) and 2,4,6-trinit rochlorobenzene (TNCB, ICN P har-
mace~ t i ca l s, Inc., Plainview, New York ) were used. 
Preparat ion of Cell Suspensions 
Epidermal cell suspensions were prepared as previously descri bed 
[14] with a few modifications. Briefly, t runkal ski n was incubated wit h 
1% trypsin , type XI (Sigma) fo r 1 h at 37"C and epidermis was 
separated from dermis. The epidermis was incubated with 0.05% DNase 
(Sigma) for 20 min and cells were separated by glass rods in Hanks' 
balanced salt solut ion (HBSS) supplemented with 10% feta l calf serum 
(G IBCO, Grand Island, New York). Spleen cells were prepared by 
gent le teas ing in HBSS. Erythrocytes were lysed by treatment with 
0.85% NH,Cl for 2 min and then washed 3 times in HBSS. 
Preparation of FITC-Conjugated Cells 
FITC-EC were prepared as previously described [15] with a few 
modifications. Brieny, single cell suspensions were washed 3 times with 
HBSS and incubated wit h FITC at a concentration of 200 JLg/ ml (pH 
9.0) f~r 15 min at 37"C. T hese cells were t hen washed 3 t imes with 
HBSS or with HBSS supplemented with 10% feta l calf serum and 
utilized fo r in vivo sensit ization. 
Prepara tion of Free FITC 
FITC was dissolved at 1 mg/ml in phosp hate-buffered sali ne (PBS, 
0.2 M, pH 9.0) and then the pH was ajdusted to 7.4 wi th PBS (pH 7.0) 
immediate ly before injection. 
Sensitization for Contact S ensitivity 
Mice were sensitized by t he epicutaneous application of hapten (400 
111 of 0.5% FITC in 1:1 acetone:d.ibutylphthalate or 100 11! of 7% TNCB 
in 4:1 acetone:olive oil ) to the shaved abdomen. Other mice were 
injected wi th free FITC or FTTC-EC via s.c., i.p. , or i.v. routes. FIT C-
EC were injected s.c. in to t he dorsal sk in using a tota l of 2 x 107/ 0.2 
mljmouse and injected via i.p. or i.v. route with a tota l of 2 x 107/ 1.0 
ml/ mouse. 
Ehcita tion af Contact Sensitivity 
Seven days after s.c., i.p. , or i. v. injection of cells or 6 days afte r 
paint ing, t he right ear was challenged with a total of 20 111 of 0.5% 
FITC in 1:1 acetone:dibutylphthalate or 20 11l of 1% TNCB in olive oi l. 
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Ear thickness was quantitated with a micrometer (Ozak i Engineering, 
Japan) and compared with t.he th ickness of the same ear prior to 
challenge. 
Assessment of Hypore.•ponsiueness 
To assess whether hyporesponsive mice were tolera nt, mice t hat 
showed little or no contact se nsitization were painted with 400 Ji] of 
0.5 % FITC on t.he shaved abdomen. Six days later, the ear was chal-
lenged with 20 1'1 of 0.5 % FITC and ear thickness was measured as 
above. The percent of suppression was calculated according to t he 
following formula: 
[ ( 
experimenta l - negat ive control )] % suppression = 1 - . x 100 
positive cont rol - negative cont rol 
Pa.~sive Transfer of Tolerance 
Seven days after i.v. injection of 1 mg of F ITC or FITC-EC, these 
mice were sacrificed and spleen cells were harvested. T hen, io x 107 
spleen cells were tra nsferred i.v. in to normal recipients, which were 
sensitized wit h FJTC painting immediately a fte r transfer. Six days 
later t hese mice were cha llenged wit h 20 1'1 of 0.5 % FITC a nd ear 
swelling was measured at 24 h. 
Treatmqnt of Spleen CelL' with Anti-Thy- 1.2 and Complement 
In order to determine whether t he cells that t ransfe rred to lerance 
were T cells, spleen cells were incubated with 1:20 of anti -Thy-1.2 
a lloantiserum (Cedarlane Lab. Onta rio, Canada) or normal mouse 
serum for 45 min at4 ' C and subsequently with 1:20 of rabbit comple-
ment (Cappel Lab. Cochranville, Pennsylvania) for 45 min at 37'C. 
These cells were then washed twice in HBSS and resuspended in 
HBSS. Then 10 x 107 anti-Thy-1.2 and complement-treated or normal 
mouse serum and complement-treated spleen cells were used for pass ive 
transfer expe riments. 
Statistical A no lysis 
The Student t-test was used to assess differences in reactivity. A p 
value of less than 0.05 was co nsidered significa nt. 
RESULTS 
Time Course of Ear Swelling After Challenge and Intervals 
Between Immunization and Challenge 
A peak response of ear swelling afte r sensit ization with FITC 
painting was observed at 24 h after challenge. No significant 
response was observed at 4 h. At 48 h the response was 
significant but somewhat less in tense than that at 24 h. Ear 
swelling was therefore measured at 24 h in this series of 
experiments. The ear swelling of mice, sensi tized with FJTC 
painting 4 days, 6 days, or 10 days before was measured. The 
response peaked on day 6. 
Induction of CS by Injection of FJTC 
In order to determine whether injection of free FITC by 
various routes can induce CS, 1 mg of FITC was injected via 
s.c., i.p., or i.v. route. Although FITC-painted mice showed 
marked ear swelling, s.c., i.p., or i.v. injection of FITC did not 
induce CS (data not shown). In order to examine whether this 
hyporesponsiveness represents immunologic tolerance, these 
FITC-injected mice were sensitized with epicutaneous appli -
cation of FIT C 7 days later. Ear thickness was measured 6 days 
after painting. Whereas s.c. injection of free FJTC did not 
suppress the CS to FITC painting, both i.p. and i.v. injection 
of FITC did suppress the CS induced by epicutaneous applica-
tion of FITC (Fig 1). 
In the following experiments to investigate the mechanism(s) 
of hyporesponsiveness to FITC, we used the i.v . route because 
the suppression was usually greater than that obtained with 
the i.p. route. Various amounts of FITC, from 0.01- 1 mg, were 
injected i.v . and t heir capabili ty to induce tolerance was meas-
ured. It was found that the higher the dose ofFITC, the stronge r 
the suppression (data not shown). Mice treated with i.v. injec-
tion of 1 mg of FITC also showed hyporesponsiveness to the 
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Ear Increments (X IQ - ' mm) 
Sensi tization Sensitization 
FITC FITC 
1 mg S .C. painting 
FITC FITC 
1 mg i.p. painting (% suppression=90%) 
FITC FITC 
1 mg i.v. painting (% suppression=96 %) 
FITC 
painting 
challenge only-
FIG l. FITC (1 mg) was injected via s.c., i.p., or i. v. route and these 
mice were sensitized with epicutaneous application of FITC 7 days 
late r. Mice injected with FITC via i.p. or i.v. route showed suppressed 
ear swelling compared to s.c. injected mice. 
Normal mice FITC 
FITC injected mice FITC 
Challenge 
only 
E ar Increments (X I 0 2 mm) 
FIG 2. Spleen cells from FITC-injected or noninjected mice were 
transferred via t he i.v. route to naive syngeneic mice (10 x 107 cells( 
mouse). Immediately afte r transfer, these mice were sensit ized with 
FITC painting. Spleen cells from FITC-injected mice showed suppres-
sion to subsequent sensitization with epicutaneous application ofFITC. 
following sensitization with s.c. injection of FITC-EC (data not 
shown). 
Transfer of Tolerance Induced by i.v. Injection of FITC 
To determine whether the tolerance induced by i.v. injection 
of FITC was transferrable with cells, spleen cells were trans-
ferred into normal mice. Immediately after transfer, these mice 
were sensitized with epicutaneous application of FITC on the 
abdomen. Mice given the spleen cells from FITC-injected mice 
showed suppressed ear swelling compared to mice injected with 
normal spleen cells (Fig 2). These results have shown t hat i.v. 
injection of FITC induced suppressor cells. 
Thy- 1.2 Positivity of the Suppressor CelLs 
Suppressor cells treated with anti-Thy-1.2 antiserum and 
complement lost their suppressor function , whereas suppressor 
ce lls t reated with normal mouse serum and complement re-
tained their suppressor activity (Fig 3). 
Hapten Specificity of Suppressor Cells 
As shown in Fig 4, the suppressor ce lls induced by i.v. 
injection of FITC suppressed the subsequent sensitization with 
FITC painting, whereas they could not suppress the CS induced 
by TNCB painting. Thus the results have shown that these 
suppressor cells can different iate FITC from TNP. 
Assessment of Sensitization by FITC-EC Injection via Various 
Routes 
Next we wanted to determine the level of sensitization re-
sulting from the administration of EC conjugated with FITC 
in vitro via various routes and compare the results with those 
obtained with TNP-EC [16). 
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Pai nt ing 
FITC 
Painti ng 
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F IG 3. Suppressor spleen cells obta ined from FITC- injec ted mice 
wer e t reated wi t h anti-Thy- 1.2 ant iserum and complement. Afte r t hese 
treatments , suppressor ce lls lost t heir supp resso r function. 
Cell T ransfer 
Normal mice 
FITC injected mice 
Normal mice 
Ear Increments (X I 0 'mm) 
Sensi tiza lion ~:::::=::::=6==8~1,:.0_ 
FITC 
FITC 
challenge 
only 
TNCB 
FITC 
FITC injec ted mice TNCB 
challenge 
only I TNCB I 
Ear Increments (X 10 · 7 mm) 
F IG 4. Immediately a fte r tran fe r of spleen cells from FITC-injected 
or noninjected normal mice, mice were sensit ized wit h T NCB pa in t ing 
o r F ITC pain t ing, respectively. S ignificant suppression was observed 
in t he case of FITC pain t ing. 
For this purpose, 2 x 107 FITC-EC were injected via s.c., i.p ., 
or i.v. routes and ear swelling was measured 7 days later . As 
shown in Fig 5, FITC-EC injected via the s.c. or i.p. route 
induced CS. However, i.v. injection of FITC-EC did not induce 
CS. In order to assess whether t his hyporesponsiveness repre-
sen ted tolerance, t hese mice were painted with FITC on t he 
abdomen and the ea r was challenged 6 days later. The mice 
in it ially injected wit h FITC-EC via i.v. route were found to be 
hyporesponsive (Fig 6). 
For t ransfer suppressor activity, 10 x 107 spleen cells from 
mice injected with 2 x 107 FITC-EC via the i.v. route were 
transferred to naive mice. These mice were then sensitized with 
F ITC paint ing and t he ea r was cha llenged 6 days later as 
desc ribed above. We could not detect any suppressor cells in 
these mice (data not shown ). 
DISCUSSION 
The resul ts of t his study extended t he in vivo studies of CS 
to another hapten, FITC. Since both FITC and TNP covalent ly 
couple to accessible amino group (primarily the f-a mino group 
of lysine res idues) of surface glycoprotein , t he FITC-conjugated 
self (FITC-self) provides the opportuni ty to study CS reactions 
specific for a structura lly distinct hapten and compares t hem 
to the cont rol mechanism(s) for the TNP-self. 
T he data presented in Figs 1- 4 resul ted from experiments in 
which FITC was injected in vivo. T hese resul ts demonstrate 
t hat i.v. or i.p., but not s.c., injection of F ITC induced hypore-
sponsiveness following the subsequent pain t ing with FITC. 
Furthermore, i.v. injection of FITC induced hapten -specific 
2 
challenge only~ 
FrTC-EC sc 
F!TC-EC ip 
FITC-EC iv ~ 
Ear increments ( x 1o·• mm ) 
4 6 8 10 12 14 16 
Fl TC painting ~=========~=3-~ 
FIG 5. FITC-conjugated epidermal cells ( FITC-EC, 2 x 107) were 
injected via s.c., i.p ., or i. v. route. Ears were challenged 7 days late r and 
ear t hickness was assessed 24 h late r. 
1 st n nd Ear lncrements (X lO- 'mm) 
sensit1zat•on sens•tization 6 10 12 14 16 18 20 
Challenge 
only 
F ITC 
painting 
FITC-EC i.v. F ITC 
pa1ntmg 
F ITC-EC i. p. F ITC painting 
F ITC-EC s.c. F ITC painting 
FIG 6. Mice sensitized wit h s.c. , i.p ., or i.v. injection with FIT C-EC 
7 days before were pa inted wit h F ITC on t he abdomen. Ear swelling 
was measured 6 days late r. S ignificant suppression was observed m 
mice sensit ized wi th i.v. injection of FITC-EC. 
suppressor T cells. These resul ts are qui te similar to t hose 
obtained with T NBS [17,18). 
In the next series of experiments, we used FITC-self with 
epidermal cells (EC). First we conjugated F ITC to EC in vitro 
and t hese cells were injected into naive mice. T he data pre-
sented in Figs 5 and 6 have shown t hat FITC-EC induced CS 
when injected via the s.c. or i.p. route. On the other hand, when 
FITC-EC we re injected via t he i.v. route, t hey did not induce 
CS but induced hyporesponsiveness to the following sensitiza-
t ion with FITC paint ing. T hese results are similar to those we 
have reported with TNP-EC [16). 
There is some cont roversy conce rning the induction of CS 
via the i.v. route using T NP-EC. Ptak et al have reported t hat 
i.v. injection of TNP-EC induced CS as assessed by ear swelling 
[19). We and others have reported that i.v. injection of TNP-
EC induced hyporesponsiveness to the fo llowing sensit ization 
with TNCB pa int ing as assessed by ear swelling [16] or foot 
pad swelling [20], respectively. T hus, we extended the obser-
vation to the structurally distinct hapten , F ITC, and obtained 
very similar results to t hose reported previously with TNP-EC 
[16]. 
Of interest was the fi nrung that we could detect hapten-
specific suppressor T cells in mice injected wit h FITC via the 
i.v. route alt hough we could not detect suppressor activity in 
spleen cells from mice injected wit h FITC-EC via t he i.v. route 
under the condit ion as described above. T here are several 
possible explanations fo r this difference. It could be due to the 
fact t hat di ffe rent suppressor mechanisms are involved in this 
hyporesponsiveness . 
In examining the mechanisms involved in tolerance induced 
by i.v. injection of DNP-SC, Claman et a! found that two 
separable pathways seemed to be involved [21) . T he first was 
a rapidly induced, long- lasting, cyclophosphamide (Cy)- insen-
sitive period of inhibit ion of reactive T -cell clones (clone inhi -
bit ion). The second pathway involves a transient, antigen-
specific mechanism which is Cy-sensit ive, and operates via the 
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activation and expression of suppressor T cells. It is tempting 
to speculate that these two mechanisms are a lso involved in 
the hyporesponsiveness to FTTC. 
Although the present study has demonstrated the induction 
of hyporesponsiveness by i.v. injection of FITC-EC, Domoto 
and Askenese have reported that they could induce CS to FITC 
by i.v. injection ofFITC-SC [1 3]. The difference in these resul ts 
is not clear at t his point. It was known, however, that in murine 
cytotoxic T lymphocyte (CTL) responses to FITC there exist 
high responder and low responder mouse strains. CTL reactions 
are also affected by FITC concent rations used for conjugation 
to ce lls [5,12]. 
In this study we used BALB/c (H-2d) mice and FITC at a 
concentration of 200 J.Lg/ml. Domoto and Askenese used CBA 
(H-2k) mice and FITC at a concentrat ion of 1000 J.Lg/ml. These 
differences, in addi t ion to the different cells used for FITC 
conjugation, may exp lain these resul ts. Studies are current ly 
under way in our laboratory. 
We wish to tha nk w Dr. Atsushi Kukita for his reviewing of this 
manusc ript , and Ms. Ak iko Moro for her technical ass ista nce. 
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